ADIL NASDAQ
Adial Pharmaceuticals, Inc.
1W: -4.0%
1M: -35.9%
3M: +39.7%
YTD: -32.5%
1Y: -56.2%
3Y: -94.3%
5Y: -99.9%
$4.12
-0.01 (-0.24%)
Weekly Expected Move ±14.6%
$3
$3
$4
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.1M
Congress—
ETF Holdings—
Key Statistics
Market Cap$10.8M
52W Range1.31-10.75
Volume64,504
Avg Volume340,322
Beta1.39
Dividend—
Analyst Ratings
Company Info
CEOCary John Claiborne
Employees5
SectorHealthcare
IndustryBiotechnology
IPO Date2018-07-27
Websiteadial.com
4870 Sadler Road
Glen Allen, VA 23060
US
Glen Allen, VA 23060
US
434 422 9800
About Adial Pharmaceuticals, Inc.
Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for the treatment of alcohol use disorder. Beyond this flagship product, the company is also exploring drug candidates aimed at providing non-opioid pain relief and addressing a range of other medical conditions. Established in 2010, Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia.
Latest News
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) Receives $15.62 Consensus Price Target from Analysts
Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's After-Market Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Young Wendy B. | A-Award | 25,666 | $2.98 | 2026-09-17 |
| Coastlands Capital L | P-Purchase | 1,233 | $2.75 | 2026-07-16 |
| Coastlands Capital L | P-Purchase | 2,000 | $2.65 | 2026-07-14 |
| Coastlands Capital L | P-Purchase | 1,700 | $2.70 | 2026-07-10 |
| Coastlands Capital L | P-Purchase | 10,053 | $2.79 | 2026-07-09 |